Cargando…

MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis

OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Illman, Jeffery E., Arunachalam, Shivaram P., Arani, Arvin, Chang, Ian Cheng-Yi, Glockner, James F., Dispenzieri, Angela, Grogan, Martha, Araoz, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405287/
https://www.ncbi.nlm.nih.gov/pubmed/29733684
http://dx.doi.org/10.1080/13506129.2018.1465406
_version_ 1783401049856409600
author Illman, Jeffery E.
Arunachalam, Shivaram P.
Arani, Arvin
Chang, Ian Cheng-Yi
Glockner, James F.
Dispenzieri, Angela
Grogan, Martha
Araoz, Philip A.
author_facet Illman, Jeffery E.
Arunachalam, Shivaram P.
Arani, Arvin
Chang, Ian Cheng-Yi
Glockner, James F.
Dispenzieri, Angela
Grogan, Martha
Araoz, Philip A.
author_sort Illman, Jeffery E.
collection PubMed
description OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-cause mortality in AL amyloidosis. MATERIALS AND METHODS: Seventy-six patients with newly diagnosed AL amyloidosis underwent cardiac MRI. 75 had images suitable for MRI FT strain analysis. MRI delayed enhancement, morphologic and functional evaluation, cardiac biomarker staging and transthoracic echocardiography were also performed. Subjects’ charts were reviewed for all-cause mortality. Cox proportional hazards analysis was used to evaluate survival in univariate and multivariate analysis. RESULTS: There were 52 deaths. Median follow-up of surviving patients was 1.7 years. In univariate analysis, global radial (Hazard Ratio (HR)=0.95, p<.01), circumferential (HR=1.09, p< .01) and longitudinal (HR=1.08, p< .01) strain were associated with all-cause mortality. In separate multivariate models, radial (HR=0.96, p=.02), circumferential (HR=1.09, p=.03) and longitudinal strain (HR=1.07, p=.04) remained prognostic when combined with presence of biomarker stage 3. CONCLUSIONS: MRI FT strain is associated with all-cause mortality in patients with AL amyloidosis.
format Online
Article
Text
id pubmed-6405287
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-64052872019-03-07 MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis Illman, Jeffery E. Arunachalam, Shivaram P. Arani, Arvin Chang, Ian Cheng-Yi Glockner, James F. Dispenzieri, Angela Grogan, Martha Araoz, Philip A. Amyloid Article OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-cause mortality in AL amyloidosis. MATERIALS AND METHODS: Seventy-six patients with newly diagnosed AL amyloidosis underwent cardiac MRI. 75 had images suitable for MRI FT strain analysis. MRI delayed enhancement, morphologic and functional evaluation, cardiac biomarker staging and transthoracic echocardiography were also performed. Subjects’ charts were reviewed for all-cause mortality. Cox proportional hazards analysis was used to evaluate survival in univariate and multivariate analysis. RESULTS: There were 52 deaths. Median follow-up of surviving patients was 1.7 years. In univariate analysis, global radial (Hazard Ratio (HR)=0.95, p<.01), circumferential (HR=1.09, p< .01) and longitudinal (HR=1.08, p< .01) strain were associated with all-cause mortality. In separate multivariate models, radial (HR=0.96, p=.02), circumferential (HR=1.09, p=.03) and longitudinal strain (HR=1.07, p=.04) remained prognostic when combined with presence of biomarker stage 3. CONCLUSIONS: MRI FT strain is associated with all-cause mortality in patients with AL amyloidosis. 2018-05-07 2018-06 /pmc/articles/PMC6405287/ /pubmed/29733684 http://dx.doi.org/10.1080/13506129.2018.1465406 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Article
Illman, Jeffery E.
Arunachalam, Shivaram P.
Arani, Arvin
Chang, Ian Cheng-Yi
Glockner, James F.
Dispenzieri, Angela
Grogan, Martha
Araoz, Philip A.
MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
title MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
title_full MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
title_fullStr MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
title_full_unstemmed MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
title_short MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
title_sort mri feature tracking strain is prognostic for all-cause mortality in al amyloidosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405287/
https://www.ncbi.nlm.nih.gov/pubmed/29733684
http://dx.doi.org/10.1080/13506129.2018.1465406
work_keys_str_mv AT illmanjefferye mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT arunachalamshivaramp mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT araniarvin mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT changianchengyi mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT glocknerjamesf mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT dispenzieriangela mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT groganmartha mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis
AT araozphilipa mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis